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Differences in the gut microbiota have been reported between individuals with autism spectrum disorders
(ASD) and neurotypical controls, although direct evidence that changes in the microbiome contribute to
causing ASD has been scarce to date. Here we summarize some considerations of experimental design that
can help untangle causality in this complex system. In particular, large cross-sectional studies that can factor
out important variables such as diet, prospective longitudinal studies that remove some of the influence of
interpersonal variation in the microbiome (which is generally high, especially in children), and studies
transferring microbial communities into germ-free mice may be especially useful. Controlling for the effects of
technical variables, which have complicated efforts to combine existing studies, is critical when biological
effect sizes are small. Large citizen-science studies with thousands of participants such as the American Gut
Project have been effective at uncovering subtle microbiome effects in self-collected samples and with self-
reported diet and behavior data, and may provide a useful complement to other types of traditionally funded
and conducted studies in the case of ASD, especially in the hypothesis generation phase.
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ifferences in the gut microbiota that inhabit the
intestinal tracts and feces of children with autism
spectrum disorders (ASD), as compared to neu-
rotypical children, have been reported by several research
groups over the past decade (15) [for comprehensive
review, see (6)]. The relationship of these differences in
the microbiota to dietary practices, the diversity and sever-
ity of clinical features, and pathogenesis remains unclear.
There is now evidence in animal models (1, 7) as well as
from more limited studies in humans, that signaling along
the gut-microbiomebrain axis is a critical regulator of
both central nervous system and immunefunction (8, 9).
In addition, some studies suggest that interventions tar-
geting the microbiome (probiotics, fecal transplants) may
have utility in the management of other neuropsychiatric
disorders (915). Further research to delineate the extent
of involvement of gut microbes in autism, and to monitor
or even suggest therapies, is therefore promising.
The role of bacteria co-associating with our gastro-
intestinal tract in physiological development and disease

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has recently attracted considerable attention, primarily as
a result of technological advances associated with sample
processing, sequencing of genetic information, and data
analytical tools. In the last decade, the revolution in
sequencing technology has fundamentally altered our
perception of microbial diversity and ecology, by enabling
us to process and analyze thousands to tens of thousands
of samples in a single study (1618). These advances have
allowed us to identify significant trends relating the phy-
siology, environment, and health history of a host and the
presence or relative abundance of the bacteria that inhabit
the host (e.g. 1921). Many factors affect the colonization
and succession of the microbial communities that live
within us, and that change over time (22, 23). It is therefore
difficult to capture the combination of events within an
individual’s life that have resulted in that individual’s
unique microbial signature. Although some bacterial taxa
correlate strongly with specific conditions (19, 24, 20, 21),
other relationships are less obvious, and may require far
larger cohorts of participants to detect (16).
Bacteria have profound influences on key aspects of our
immune regulatory network (25), with far-reaching im-
plications for our physiological and even neurological
development (26). Direct association between bacteria and
host cells is important for immunological development
(27), regulation, and response (28). However, bacterial bio-
mass in the lumen, including bacteria that do not actively
associate directly with host gastrointestinal tissues, might
be more important for the production of key metabolites
that can have important physiological effects once they
cross into our bloodstream [e.g. 4-ethyl phenyl sulfate
(4-EPS) production (1)]. Bacteria contribute to circulating
blood levels of amino acids such as tryptophan (including
synthesis from dietary serine or indoles), thereby affecting
levels of key regulatory neurotransmitters, such as seroto-
nin, and also regulate levels of neuroactive metabolites
along the tryptophan degradation (kynurenine) pathway
both in the intestine and in the blood (8, 2931). Although
the common method for assessing a gut microbial com-
munity is through the feces, in some circumstances such as
inflammatory bowel disease (IBD), mucosal biopsies may
help identify bacterial associations that may not be evident
in fecal samples, especially in cases where mucosally asso-
ciated bacteria are not dominant in the fecal sample (32).
The importance of experimental designs: cross-
sectional versus longitudinal analysis
Given the heterogeneity of ASD and the many poten-
tial confounding factors that may influence microbial
diversity, looking for associations in very large and well-
characterized cohorts may be the key to finding associa-
tions between the gut microbiota and disease. Large-scale
efforts such as the Earth Microbiome Project (17) and
American Gut (http://americangut.org) have demon-
strated the willingness of large communities of researchers,
and even of the general public, to contribute thousands of
samples to provide a fuller picture of the microbial
diversity of our planet and our bodies. In particular,
aggregating longitudinal datasets from different microbial
habitats is starting to provide an understanding of
dynamics on different timescales (33), and extending these
to studies of people with different clinical conditions
provides an especially exciting opportunity at present.
Cross-sectional study designs
Cross-sectional study designs are useful for identifying
systematic patterns across a population, testing the hypo-
thesis that some component of microbial variation within a
population is correlated with a study parameter (e.g. ASD
diagnosis). Applying a cross-sectional study design to very
large cohorts, for instance thousands of subjects, may
provide the statistical power to elucidate subtle phenom-
ena when faced with many confounding factors, as is
common in microbiome studies where lifestyle, diet, age,
genetics, and disease play important roles in shaping
community structure.
The benefit of a large cross-sectional study design was
demonstrated during an early analysis of the American
Gut dataset (http://americangut.org). At first, patterns
driven by diet and other lifestyle choices were observed,
but statistical significance suffered from limited sample
sizes within the specific groups of subjects showing
interesting trends. As we collected thousands of addi-
tional samples, many of these groups reached sample
sizes that increased the confidence and significance of the
observed patterns. One such pattern was a population-
scale seasonal effect, in which samples collected from in-
dividuals during the holiday season in the United States
tended to have higher diversity within each sample (http://
nbviewer.ipython.org/github/biocore/American-Gut/blob/
master/ipynb/Alpha diversity notebook.ipynb). Empiri-
cal power estimations suggest around 100 samples per
group are required to reliably observe these subtle differ-
ences across seasons, even after matching individuals for a
variety of other factors (http://nbviewer.ipython.org/github/
biocore/American-Gut/blob/master/ipynb/Power.ipynb).
These more subtle patterns only appeared through the
collection of a large number of samples from a broad
cross-section of the population, making it possible to
detect the signal against high levels of background noise
coming from other factors.
Another recent microbiome study that focused on
Crohn’s Disease patients (32) and relied on a large cross-
sectional design also benefitted greatly from a large sample
size. Critically, the researchers noted that the number of
samples was more important than sequencing depth (the
number of sequences collected from each sample) for
detecting statistically significant patterns that were appar-
ent in the full dataset. The study design allowed conclu-
sive identification of key taxa that differentiate Crohn’s
Daniel McDonald et al.
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patients from healthy controls that had not previously
been reported as associated with Crohn’s. Interestingly,
once the specific taxa were identified, it was then possible
to assess whether the metabolic potential of these organ-
isms made sense in the context of the disease. In this case,
some of the microbes that are less abundant in Crohn’s
patients are involved in the production of butyrate, which
is a short-chain fatty acid (SCFA). Butyrate is consumed
by intestinal epithelial cells (34), which are instrumental in
initiating an immune response (35, 36). In addition, the
researchers were able to identify an amplification effect
from antibiotic usage, in which individuals who had
recently taken antibiotics had a significantly pronounced
increase in detrimental taxa observed in Crohn’s patients,
with a corresponding decrease in beneficial taxa. One
taxon in particular, Fusobacterium, was recently found to
be highly correlated with colorectal cancer (37), which has
a higher incidence in Crohn’s and IBD patients. These
observations suggest antibiotic usage by this population
should attract closer scrutiny due to the increased risk to
the patient [although it should be noted that the specific
effects of antibiotic usage in healthy individuals is still
poorly understood, and appears to be highly variable in
different subjects (38, 39)]. A parallel study in ASD,
especially one relating differences in the microbiota to
common interventions such as drugs targeted at resolving
gastrointestinal symptoms, antipsychotics, antidepres-
sants, dietary changes, and other treatments, and with
excellent clinical data, could be especially valuable in
understanding which changes in the microbiome are likely
to be associated with ASD symptoms and which are most
likely to be side-effects of treatment.
Longitudinal study designs
Although cross-sectional studies are useful, they cannot
provide insight into variation within an individual over
time, limiting their power to observe phenomena such
as succession and to factor out between-subject variation
in diseases with complex etiologies. Such questions can
only be addressed with longitudinal study designs, exam-
ining multiple timepoints from the same individual.
Ecological succession of the gut microbial community is
of particular interest in autism because microbial com-
munities play a central role in training the immune
system during childhood development (22). Early anti-
biotic usage, for example, is associated with an increase in
allergies and obesity (40, 41), and may be associated with
disrupting the maturation of the microbiome. Within the
human microbiome, an infant’s initial microbial commu-
nities depend on delivery mode (42), where the infant
fecal community tends to resemble the mother’s vaginal
community after vaginal birth, but instead resemble skin
after C-section. Koenig et al. (22), through a 3-year time
series tracking a newborn, monitored this succession,
revealing a large amount of change over time progressing
from a vaginal-like community to a community resem-
bling the adult fecal state (43). One particularly interest-
ing observation was a substantial regression in community
state as a result of the child receiving antibiotics. This
regression was rapidly ameliorated, suggesting that resi-
lience in the community is picked up relatively early in
life. However, the impact that these types of disruptions
can have on the fledgling immune and endocrine systems
is not yet known, nor is the magnitude of this impact
with respect to other environmental, dietary, and lifestyle
factors.
Some important general considerations in longitudinal
study designs include how frequently to sample, whether
to focus timepoints around defined interventions, and
what auxiliary data (e.g. diet or immunological data) need
to be collected at each timepoint versus assessed once for
each subject. In general, not enough studies have been
done in order to provide detailed guidance on these points,
and animal model studies can be misleading. For example,
on the basis of studies on mice, which respond within 1 day
to dietary shifts (44, 45), we performed a parallel dietary
intervention study in humans with very little effect after
10 days in an inpatient setting (46). However, longitudinal
studies of the effects of microbiota transfer from humans
to mice have been very useful for elucidating effects of
microbiomes associated with obesity (47) and malnutri-
tion (48), and the same is likely to be true for autism (49)
given the availability of mouse models (1). Given the
established role of gut microbiota in allergen sensitization
in mouse models (28), and given high variability among
individual animals as well as among individual humans,
understanding effects of changes in the microbiome in
response to defined perturbations is likely to benefit
considerably from animal model work even when details
of the timescale or nature of the response differ among
species.
Longitudinal studies of the human microbiome to date
have typically employed small sample sizes, limited time-
points, or both. For example, the NIH-funded Human
Microbiome Project (16) reported data from only two
timepoints in each of 250 subjects. Only a couple of daily
studies of apparently healthy adults have employed sam-
pling durations as long as a year (50, 51), and a recent study
of dozens of healthy students employed only weekly
sampling (52). Nonetheless, it is clear that dynamics are
shaping up to be an important aspect of the human gut
microbiome, and studies both of the baseline dynamics
of the microbiome in ASD subjects, and of dynamics in
response to treatment with different interventions aimed
at alleviating different ASD symptoms, hold considerable
potential both for stratified treatment and for develop-
ing a better biological understanding of the underlying
mechanisms.
Toward defining the gut microbial community structure of ASD patients
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Comparison of study designs with respect to
neuropsychiatric disorders
Within the context of neuropsychiatric disorders, cross-
sectional designs have been instrumental in recognizing the
correlation between the presence of blood markers of
inflammation or intestinal barrier compromise and de-
pression (53), bipolar disorder (54), and autism (6, 55).
The pathogenesis of these diseases differs. However, the
implication of inflammation in such a broad range of
disorders suggests that inflammation, and both its cause
and effect, ought to be a focal point for investigation. In
particular, inflammation can lead to a permeable gut,
thereby allowing metabolites produced by gut inhabitants
(and even the inhabitants themselves, or fragments of
them) to leak into the bloodstream (56, 57), and some
metabolites can even pass the blood/brain barrier (58). On
the other hand, the predominant source of serotonin in the
body is within the large intestine, and it is the role of
enterochromaffin cells to synthesize serotonin from tryp-
tophan (8). Dysregulation of the gut microbiome can
trigger secondary effects in these cells that alter the rate of
serotonin production (59), with significant changes in
neuropsychiatrically relevant domains, including mood
(60) and satiety (61) and possibly, the stereotypic features
of autism (62, 63). Interestingly, some of the classes of
drugs prescribed for treatment of neuropsychiatric dis-
orders act on the gastrointestinal tract and may also affect
the immune system (59). One metabolite of interest is 4-
EPS, originally observed to be significantly increased in
serum in a mouse model of autism (1) [fascinatingly, this
model requires stimulating the mother’s immune system
prior to birth, resulting in offspring with autism-like
symptoms (64)]. Anorexia Nervosa is an eating disorder
characterized by the inability or unwillingness to gain
weight (65, 66). ASD is a comorbidity for anorexia, and
may be reflective of sociocommunicative problems within
individuals with anorexia (6769). The microbiome plays a
role in the pathology of anorexia; the bacterial ClpB heat
shock protein can induce anti a-MSH antibody, leading to
a reduction in appetite, weight loss, and anxiety (70, 71).
The importance of controlling for technical
variables in traits with small effect size
The problem of large versus small effect sizes is in some
ways analogous to assessing the riskof a campfire sparking
a wildfire. If you asked: are campfires correlated with
wildfires, the answer is likely to be yes by analysis of
whether wildfires are more likely in proximity to camp-
grounds. A large amount of variation in the type of camp,
its geographic location, and definition of wildfire can likely
be tolerated. In this case, the presence of a fire is a large
effect. If instead you asked: are certain personality types
more likely to spark a wildfire from a campfire, then the
answer is subtle necessitating finer control over data
collection. For instance, how personality type is assessed
is critical in assuring that everyone underwent the same
test and that there was no researcher bias in test admi-
nistration. In addition, controlling for substance use is
necessary in order to understand whether it is personality,
or say, the presence of alcohol that leads to accidental
wildfires. In this case, the potential small effect of perso-
nality (which is a large effect in other contexts) requires
more careful control, relative to the large effect of simply
having a campfire, in order to properly identify if in fact
there is an effect mediated by personality.
The complexity of neurological disorders, and the
difficulty to date in pinpointing specific causes, suggests
that the causes themselves are varied, subtle, and possibly
multifactorial. As such, emphasis on controlling for
technical variables is essential to minimize noise, and
maximize signal. For instance, the Human Microbiome
Project sequenced two separate regions of the 16S rRNA
gene (16) from the same samples leading to a confound-
ing effect if analyzing both loci together. The end effect
was that it was not feasible to compare data from one loci
to another as the noise stemming from the loci masked
any usable signals in the data. On a practical level, using
the exact same protocols for all samples of a common
type is critical in order to limit the impact of technical
bias. Frustratingly, there is even variation that is intro-
duced into the data by the site that is processing the
samples, though there are ongoing efforts to understand
the drivers of this variation so that it can be normalized,
something that is necessary for clinical applications of
microbiome assays.
Digging deeper, in addition to tightly controlled tech-
nical variables and large sample sizes, using a tiered
systems approach can substantiate interpretation and
validation. This is particularly useful within studies of
autism as there is evidence for genetic predispositions that
may ‘activate’ through an environmental trigger, where the
microbiome is considered part of the environment. The
systems approach can greatly improve the understanding
of the roles particular organisms are undertaking. From
16S rRNA data, it is possible to predict a likely functional
metagenomic profile (72), but it is not feasible to predict
the specific metabolites being produced, which will to a
certain extent be modulated by the availability of fermen-
table substrates, and other sources of energy for microbes.
These metabolites are the vector of communication be-
tween microbes, and between microbes and the host.
Similarly, knowing the genetic makeup of the host is
informative, but it cannot be used to determine a specific
immune response. A tiered approach that includes im-
munological markers, metabolite profiles, and microbial
community data sampled at near the same time point
enables researchers to tightly validate observations be-
tween levels, and truly begin to understand the dynamics
of disease.
Daniel McDonald et al.
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The influence of diet on the microbiome
Perhaps unsurprisingly, what one eats can influence the
composition of the microbiome. Long-term diet has one
of the largest known effects on the human gut micro-
biome: in particular, the balance of carbohydrates to
animal protein affects the balance of Prevotella sp. to
Bacteroides sp., driving the largest component of overall
patterns in the human microbiome within healthy adult
Western populations (46). Cross-culturally, societies with
high-grain, low-animal diets also tend to have far more
Prevotella at the expense of other major gut taxa (23).
Most short-term dietary changes have been far more
modest. However, on the extreme end, shifting to a heavy
animal product diet characterized by meats and cheese
can, on very short time scales, increase abundance of bile-
tolerant organisms (73). The increase in these organisms
is negatively correlated with acetate and butyrate stem-
ming likely from the reduced fiber load available for
microbial fermentation. Butyrate has previously been
observed to modulate colonic regulatory T-cell differen-
tiation in murine models (74), and is of particular interest
within the study of neurological disorders due to the
observed relationships with gut inflammation. The role of
dietary gluten and casein in the etiology of ASD remains
of intense interest to the community, but strong evidence
to date has been scarce [reviewed in (75)].
Propionic acid, a SCFA produced by the microbiome
from fermentable dietary carbohydrates (76), has been
associated with ASD in rat models (58). ASD-like symp-
toms, including a neuroinflammatory response, can be
induced from intraventricular infusion of propionic acid
(58) resulting in significant changes in behavior and social
interaction (77). However, pathology might only occur
in individuals with genetic and/or acquired aberrations in
metabolism, since in healthy individuals SCFAs are
primarily metabolized in the liver (76), again indicating
that associations between gut microbiota and ASD may
also involve other underlying genetic factors. In healthy
individuals, propionic acid potentially can increase feel-
ings of satiety, lower carcinogenesis and cholesterol (78)
and possibly have an anti-inflammatory effect (79). See
(78) for an in depth review of propionate, including a
discussion on fermentable substrates.
The possible role of vitamin D in ASD is also intriguing.
Dark/yellow skin requires increased ultraviolet (UV) B
exposure to induce sufficient vitamin D in low sunlight
regions/seasons (80). This effect is particularly accentuated
among Somalian and other immigrants from sub-Saharan
Africa with fundamentalist practices leading to full body
cover (81). There are also dietary practices [avoidance of
vitamin D-enriched dairy products, and other common
staples such as maize (82)] that may exacerbate deficiencies
in vitamin D relating to reduced UVB exposure, con-
tributing to Th1 skew/altered intestinal inflammatory state
(83) as well as frankly increased risk of some infectious
diseases such as tuberculosis (81). In the context of vitamin
D deficiency (and perhaps also with low levels of litho-
cholic acid), vitamin D receptor (VDR) expression should
be increased (84, 85). VDR has been reported to negatively
regulate intestinal NFkB (and therefore downstream
innate immune signaling) induced by bacteria, and bacteria
also regulate VDR expression (86). This may be an im-
portant mechanism for explaining the role of vitamin D
deficiency in autoimmune diseases, perhaps through a
Th17 mechanism involving bacteria that play roles similar
to the regulatory roles that segmented filamentous bacteria
(SFB) play in mice (8789).
Although we have a limited understanding of how diet
influences the microbiome in the short-term [through
extreme changes (73)] and more long-term phenomena
(90), we do not yet understand how to manipulate diet to
guide a microbial community from one state to another
(e.g. from disrupted to healthy). One aim of the American
Gut Project is to characterize diet and its impact on the
microbiome, with the hope of elucidating systematic
differences  if they exist  between dietary restrictions
(e.g. vegetarians and paleo eaters). Unfortunately, the
reliability of dietary data collected from the general public
is often low. Even the recall of individuals for meals
consumed over the course of a week can be compromised
(91). The first attempt at collecting detailed diet informa-
tion by the American Gut Project yielded limited results
(though a correlation in diversity with the number of
different types of plants consumed was observed). Vari-
ables such as the approximate percentage of fat consumed
over the course of a week had incredible variance and in
many cases were outside of reality. In its second attempt at
diet, the American Gut Project decided to take a two-
pronged approach, one using a generalized diet question-
naire that lacked free text entry and contained questions
about the frequency of consumption (e.g. in an average
week, how often do you consume at least 23 servings of
fruit in a day?), and the second to use a validated food
frequency questionnaire through a professional service
called Vioscreen.
Correlation versus causation
As noted above, several intriguing correlations have been
observed between ASD and the gut microbiota. However,
establishing causality is challenging. In particular, gut
barrier dysfunction is a common comorbidity of ASD, but
is known itself to affect the microbiome both in humans
and mouse models. Therefore, appropriate controls need
to be selected carefully so that the effects of ASD itself are
not confounded with the effects of gut barrier dysfunction.
Longitudinal studies can help resolve these types of issues,
for example, by testing whether changes in the microbiota
associated with ASD precede or follow gut barrier
dysfunction issues within a subject, although very limited
data are available at present.
Toward defining the gut microbial community structure of ASD patients
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In mouse models causality is easier to establish because
symptoms that model ASD can be induced experimen-
tally and the ability to administer microbially based
therapies is substantially greater. The best example of this
to date is the MIA study described above (1), wherein
autism-like symptoms can be traced to specific metabo-
lites produced by the microbiome, and even reversed
using probiotics. For other conditions, including malnu-
trition (48) and obesity (47), causal pathways may be
uncovered by transplanting microbes from humans with a
different physiological state into mice and demonstrating
that aspects of the phenotype can be recaptured, either
using fecal samples directly or using large collections of
strains of bacteria isolated from individual fecal speci-
mens (the latter providing evidence that only the bacteria
are involved, as metabolites, viruses, antibodies, etc. are
not transferred in these experimental designs). These
types of studies therefore hold considerable promise for
unraveling causality in ASD (49).
Conclusion
The lifestyle and dietary choices of individuals affected by
ASD span a broad range, complicating analyses. As was
the case with Crohn’s Disease, the ability to observed
subtle, and informative patterns depends on large sample
sizes that are only feasible in cross-sectional study designs.
Longitudinal designs, on the other hand, offer perspective
into the change of a community over time, allowing tests of
hypotheses about factors leading to a change in state
within an individual (e.g. is a measured parameter such as
disease severity modulated by changes in the microbiome)
and whether a change in the microbial community happens
prior to observable changes in individual state (e.g.
reported severity) or vice versa, allowing inferences about
causality. As we learned with the American Gut Project,
the general public is extremely interested in microbiome
research at present, and providing appropriate mechan-
isms to engage the public is an effective means to get to
sufficient sample sizes to have the power to detect subtle
differences in the data. Longitudinal studies, due to the
high level of dedication over an extended period, cannot
reach comparable sample sizes due to their expense. Given
that a large sample size is more difficult in these designs,
strict exclusion criteria must be defined to minimize
confounding factors, maximize the signal, and maintain
a high probability that the individuals will continue to the
end of the study.
Studies of associations between ASD and the micro-
biome have generated a number of intriguing hypotheses
about how microbes could be involved in the etiology of
ASD. However, there are many confounding variables,
such as diet and gastrointestinal comorbidities, as well
as technical variation among studies and background
microbiome differences among cohorts, that complicate
analysis. Several approaches are likely to be exceptionally
valuable in resolving such complexities: 1) access to large,
cross-sectional cohort studies that can help generate
hypotheses about combinations of factors that may have
a strong influence on ASD outcomes, particularly if inter-
acting in a nonlinear way; 2) longitudinal studies that
allow high inter-individual variability in the microbiome
to be factored out yet provide data regarding associations
with progression within each individual to be revealed,
potentially helping to get closer to causal pathways; and
3) animal model research including microbiome transfers
and administration of candidate probiotics that will
facilitate rapid progress toward understanding whether
the microbiome plays a causal or contributory role in some
subsets of ASD.
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